Unknown

Dataset Information

0

Trivalent soluble TNF Receptor, a potent TNF-? antagonist for the treatment collagen-induced arthritis.


ABSTRACT: Tumor necrosis factor is a major pro-inflammatory cytokine which triggers various physiological consequences by binding to and trimerizing its receptors, and has been the single most sought-after drug target for intervening autoimmune diseases such as rheumatoid arthritis and psoriasis. However, current TNF-? blockers, including soluble receptor-Fc fusion and therapeutic antibodies, are all dimeric in structure, whereas their target TNF-? itself is homotrimeric in nature. Here we describe the development of a trivalent soluble TNF receptor and show that it is a more potent than the dimeric TNF receptor decoys in inhibiting TNF-? signaling both in vitro and in vivo. The process involves gene fusion between a soluble receptor TNFRII with a ligand binding domain and a trimerization tag from the C-propeptide of human collagen (Trimer-Tag), which is capable of self-assembly into a covalently linked trimer. We show that the homotrimeric soluble TNF receptor (TNFRII-Trimer) produced with such method is more potent in ligand binding kinetics and cell based bioassays, as well as more efficacious in attenuating collagen-induced arthritis (CIA) in a mouse model than its dimeric TNFRII-Fc counterpart. Thus, this work demonstrates the proof of concept of Trimer-Tag and provides a new platform for rational designs of next generation biologic drugs.

SUBMITTER: Cui X 

PROVIDER: S-EPMC5943350 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis.

Cui Xiaofang X   Chang Linmo L   Li Youwei Y   Lv Qianrui Q   Wang Fei F   Lin Yaxian Y   Li Weiyang W   Meade Jonathan D JD   Walden Jamie C JC   Liang Peng P  

Scientific reports 20180509 1


Tumor necrosis factor is a major pro-inflammatory cytokine which triggers various physiological consequences by binding to and trimerizing its receptors, and has been the single most sought-after drug target for intervening autoimmune diseases such as rheumatoid arthritis and psoriasis. However, current TNF-α blockers, including soluble receptor-Fc fusion and therapeutic antibodies, are all dimeric in structure, whereas their target TNF-α itself is homotrimeric in nature. Here we describe the de  ...[more]

Similar Datasets

| S-EPMC8322419 | biostudies-literature
| S-EPMC5752453 | biostudies-literature
| S-EPMC6375885 | biostudies-literature
2009-10-20 | E-MEXP-2404 | biostudies-arrayexpress
| S-EPMC5196888 | biostudies-other
| S-EPMC9874074 | biostudies-literature
2010-08-21 | GSE23731 | GEO
| S-EPMC7033619 | biostudies-literature
| S-EPMC7394479 | biostudies-literature
| S-EPMC3311775 | biostudies-literature